dr. wang on correlative data from the zuma-2 trial in mcl
Published 4 years ago • 43 plays • Length 0:58Download video MP4
Download video MP3
Similar videos
-
1:26
dr. miklos on the results of the zuma-2 trial in mcl
-
0:54
dr. wang on updated data with single-agent acalabrutinib in mcl
-
1:19
dr. wang discusses the zuma-2 trial in mantle cell lymphoma
-
1:59
dr. wang on ongoing research in mcl
-
1:59
michael wang, md, shares details from the zuma-2 trial in mantle cell lymphoma presented at ash 2019
-
0:55
dr. wang on the evolution of treatment in mcl
-
1:22
dr. zonder on the zuma-2 and zuma-5 trials in mcl and inhl
-
1:51
dr. wang on research trends in mcl
-
23:23
doctors' die-logues: professor william hwang
-
33:18
doctors' die-logues: professor john eu-li wong
-
17:26
doctors die-logues: dr tan yia swam
-
0:47
dr. wang on the safety profile of kte-x19 in mcl
-
1:08
dr. wang discusses the future of treatment in mcl
-
0:51
dr. wang on precision medicine in mcl
-
1:04
dr. wang on the safety profile of brexucabtagene autoleucel in relapsed/refractory mcl
-
3:54
zuma-2: outcomes of r/r mcl patients who progressed within 24 months of diagnosis
-
1:57
dr. wang on combatting car t-cell therapy resistance in mcl
-
1:20
dr. wang on the safety and efficacy of kte-x19 in r/r mcl
-
1:22
zuma-2 trial demonstrates efficacy in mantle cell lymphoma
-
2:19
dr. wang on the fda approval of brexucabtagene autoleucel in mcl
-
0:58
dr. wang discusses acalabrutinib in mcl
-
1:19
dr. wang on triplet vorinostat regimen in newly diagnosed mcl